This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, R. J. Articles by Zusman, R. Search for Related Content PubMed PubMed Citation Articles by Anderson, R. J. Articles by Zusman, R.

Hypertension, Vol 17, 636-642, Copyright © 1991 by American Heart Association

ARTICLES

Once-daily fosinopril in the treatment of hypertension

RJ Anderson, KL Duchin, RD Gore, TS Herman, RS Michaels, PS Nichola, TM Nolen, P Wolfson, DG Wombolt and R Zusman
University of Colorado, Denver.

This multicenter, dose-ranging study evaluated the antihypertensive effectiveness of once-daily administration of fosinopril sodium in 220 patients with supine diastolic blood pressure of 95-115 mm Hg. After a 4-week placebo period, patients were randomly assigned to double-blind therapy with either placebo or 10, 40, or 80 mg fosinopril once daily for 4 weeks. If treatment goals were not met, chlorthalidone 25 mg/day was added for weeks 5 to 8. Thereafter, patients could enter the long- term, open-label phase and receive 10-80 mg/day fosinopril plus chlorthalidone, if needed. After 4 weeks of monotherapy, the average decreases in supine diastolic blood pressure were 9% (10 mg), 11.5% (40 mg), and 12.5% (80 mg) compared with 6% in the placebo group. After 8 weeks, the average decreases, with or without diuretic therapy, were 12.5-18.2%, compared with 10.8% with placebo. Blood pressure continued to be well controlled, and the patients showed no evidence of tachyphylaxis or tolerance through 12-15 months of treatment. Fosinopril was well tolerated. During the short-term phase, no patient withdrew because of adverse events possibly related to fosinopril; during the long-term phase, nine of 148 patients (6.1%) withdrew for that reason. In patients with mild-to-moderate hypertension, once-daily fosinopril (40 and 80 mg) provided significant antihypertensive effects with or without diuretic therapy. The 10 mg dose was effective in some patients and may be considered a starting dose.

This article has been cited by other articles:

				J. S. Li, K. Berezny, R. Kilaru, L. Hazan, R. Portman, R. Hogg, R. D. Jenkins, P. Kanani, C. M. Cottrill, T. K. Mattoo, et al. Is the Extrapolated Adult Dose of Fosinopril Safe and Effective in Treating Hypertensive Children? Hypertension, September 1, 2004; 44(3): 289 - 293. [Abstract] [Full Text] [PDF]

				N. Mainville and W.E.S. Connolly Acute visual loss after initiation of antihypertensive therapy: case report Can. Med. Assoc. J., August 19, 2003; 169(4): 313 - 315. [Abstract] [Full Text] [PDF]

				C.-H. Chen, C.-T. Ting, S.-J. Lin, T.-L. Hsu, F. C. P. Yin, C. O. Siu, P. Chou, S.-P. Wang, and M.-S. Chang Different Effects of Fosinopril and Atenolol on Wave Reflections in Hypertensive Patients Hypertension, May 1, 1995; 25(5): 1034 - 1041. [Abstract] [Full Text]